Clinical Trials Logo

Aging clinical trials

View clinical trials related to Aging.

Filter by:

NCT ID: NCT05433233 Completed - Hypertension Clinical Trials

Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension

Start date: September 9, 2020
Phase: N/A
Study type: Interventional

Eight out of ten older adults have hypertension in the US, which is a strong risk factor for cardiovascular events. To manage hypertension, regular and structured exercise is effective and strongly recommended regardless of drug therapy. However, structured exercise is often performed in a health club, could be difficult, and warrants caution in older adults with chronic conditions. In contrast, the most common lifestyle physical activity in older adults is walking, which is inexpensive, easy, and safe. Recent technological advancement in activity monitoring provides reliable step counts and promotes lifestyle walking. Although one of the most popular public health goals is walking 10,000 steps/day, recent studies found that it is unrealistic and difficult to achieve. Further, there is very little evidence whether walking 10,000 steps/day is effective, specifically in older adults with hypertension. Walking 3,000 extra steps/day 5 days/week is equivalent to meeting the current aerobic physical activity guidelines, as it takes about 30 minutes each day, and is more realistic and achievable. Steps/day is easy to understand and captures most physical activities in older adults. However, there are no specific guidelines about how many daily steps are needed for older adults in the current physical activity guidelines. Thus, this project is aimed to provide pilot data to answer a simple, but unknown, question about physical activity in older adults: "Can increasing lifestyle walking in older adults with hypertension reduce blood pressure? And can older adults maintain a lifestyle walking intervention on their own?". This project will significantly contribute to developing more effective and easy physical activity guidelines for older adults.

NCT ID: NCT05422885 Completed - Aging Clinical Trials

Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease

STAMINA
Start date: May 20, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this pilot study is to demonstrate the safety and feasibility of administering intermittent doses of Dasatinib and Quercetin (D+Q) in older adults at risk of Alzheimer's disease (AD). The study will evaluate whether giving D+Q may improve cerebral blood flow regulation, mobility, and cognition in older adults, and thus may prevent progression to Alzheimer's disease.

NCT ID: NCT05420142 Completed - Aging Clinical Trials

Determination of In-vivo Plasma AA Appearance From Plant Protein Fibre Products

Start date: March 14, 2022
Phase: Phase 2
Study type: Interventional

This study aims to assess the digestibility and efficacy of the study groups previously developed innovative plant-based protein and fibre products.

NCT ID: NCT05418270 Completed - Aging Clinical Trials

Anorexia and Personality Traits in Elderly Individuals

APETI
Start date: June 2, 2022
Phase:
Study type: Observational

The aim of this study is to evaluate the relationship between age-related anorexia and personality traits in elderly individuals with comorbidities.

NCT ID: NCT05409404 Completed - Aging Clinical Trials

The Effects of 8 Weeks Post Exercise Hot Water Immersion on Vascular and Cardiometabolic Health in Physically Inactive Middle-aged Adults

Start date: January 13, 2023
Phase: N/A
Study type: Interventional

This research project aims to determine whether post exercise hot water immersion can improve vascular and cardiometabolic health to a greater extent than post exercise thermoneutral water immersion in healthy middle-aged adults. The study will take place over an 8 week period where participants will do a combination of aerobic exercise and water immersion 3 times per week. The study will be a randomised controlled trial comparing 8-weeks of post exercise hot water immersion (EX+HWI) to post exercise thermoneutral water immersion (EX+TNWI).

NCT ID: NCT05399966 Completed - Aging Clinical Trials

Effects of Monarda Didyma Extract Supplementation on Biological Ageing

EMODISU
Start date: February 28, 2023
Phase: N/A
Study type: Interventional

This research aims to explore the potential benefits of supplementation of a natural ingredient, the Monarda didyma extract, to reduce / delay the biological aging of a susceptible population, thus contributing to two relevant topics in science with important social and economic implications: anti-aging strategies for wellness and healthy aging and environmental sustainability using natural products.

NCT ID: NCT05390008 Completed - Aging Clinical Trials

The Effects of PFMT and MPE in Elderly Women With SUI.

Start date: July 20, 2020
Phase: N/A
Study type: Interventional

The aim of the study was to compare the effects of PFMT and MPE on SUI frequency and explosure from symptoms, PFM activation response and strength of lumbar stabilizing muscle in elderly women with SUI.

NCT ID: NCT05385874 Completed - Aging Clinical Trials

Risk Prediction and Its Intelligent Assessment for Cognitive Impairment Among Community-dwelling Older Adults

Start date: April 1, 2022
Phase:
Study type: Observational

Cognitive impairment is one of the core early signs of dementia, and it is also a key stage for community-based dementia prevention. Accurate and convenient prediction of cognitive impairment can help the community to identify and manage the high-risk population of dementia. Previous studies had developed several dementia predicting models, but such models may be not suitable for cognitive impairment prediction. Based on the national representative follow-up data of Chinese Longitudinal Healthy Longevity Survey (CLHLS), this project aims to develop and validate a brief cognitive impairment prediction algorithm among the community-dwelling elderly, using machine learning methods (such as Logistic regression, Naïve Bayes model, Extreme Gradient Boosting Tree and so on). Finally, based on the constructed model, an easy-to-use online intelligent assessment tool for predicting cognitive impairment risk will be developed. The general practitioners, social workers and the elderly would be invited to use the tool and we will revise the tool according to their suggestions and comments. This project is expected to provide scientific basis and technical support for community-based dementia prevention, and will also be useful for the elderly to easily understand their cognitive health.

NCT ID: NCT05380180 Completed - Aging Clinical Trials

Enhancing Quality of Life for Older Adults With and Without Mild Cognitive Impairment (MCI) Through Social Engagement Over Video Technology

Start date: April 15, 2022
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to rigorously assess the efficacy of an 8-week social engagement OneClick intervention. A total of 120 older adults with and without mild cognitive impairment (60 per group) will be randomized after a baseline assessment to the social engagement OneClick intervention group or the waitlist control group. Participants assigned to the intervention group will receive the social engagement OneClick intervention for 8 weeks, and will complete a mid-assessment at week 4, and a post-assessment at week 8. Participants assigned to the waitlist control group will receive no intervention for the first 8 weeks and will complete assessments at week 4 and week 8. Subsequently, as an extension to this study, participants assigned to the waitlist control group will have an opportunity to participate in 8 weeks of social engagement OneClick intervention, with intervention effects assessed at week 4 and week 8.

NCT ID: NCT05330780 Completed - Aging Clinical Trials

Breathing Room Intervention to Achieve Better Lung Health in Older Adults

Start date: February 22, 2022
Phase: N/A
Study type: Interventional

This proposed study will evaluate whether a novel nonpharmacological intervention, Breathing Room, can improve lung function in the target population of older adults. Therefore, the primary aim of this pilot is to examine the effect of Breathing Room on inspiratory muscle strength, spirometry confirmed ventilatory function (Forced Expiratory Volume in one second (FEV1), Forced Vital Capacity (FVC) and FEV1/FVC), functional status, posture, physical activity, and lower respiratory infection rates.